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Introduction
Thyroid carcinomas are usually papillary or follicu-
lar tumors, arising from the thyroid follicles. Until now,
it is believed that multifocal tumors are, in majority, vari-
ants of papillary carcinomas. Estimates of the frequen-
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Aim. To study the frequency of multifocality in well-differentiated
non-medullary thyroid carcinomas and correlate it with various epide-
miological factors, as well as with patients’ survival.
Patients and methods. A retrospective study was conducted on 80
patients who underwent total thyroidectomy from January 1985 to De-
cember 2004 in the First Department of Surgery of University General
Hospital of Alexandroupolis, Democritus University of Thrace, Greece,
for well-differentiated non-medullary thyroid cancer (papillary and fol-
licular). Patients’ medical records and demographics, including age, gen-
der, histological type (papillary, follicular), multiple foci of tumors, ove-
rall and specific survival were analyzed.
Results. Multifocality was established in 17/80 patients (21,25%).
Multifocal tumors were found in 4/20 male patients (20%) and 13/60
female ones (21,67%), percentages which are almost identical. Increa-
sed rates of multifocal tumors were found in the age groups of 20-29, 30-
39 and 70-79 years old, while low rates were documented in the age grou-
ps of 0-9, 10-19 and 60-69 years old. Follicular tumors had a 20% rate,
similar to papillary tumors (22,2%), and an impressive multifocal rate
of mixed papillary-follicular neoplasms (75%) was found. Finally, sur-
vival was not found to be influenced by the multifocality of the tumor,
under the prerequisition that total thyroidectomy is applied.
Conclusions. Multifocality should not be considered as a “privile-
ge” of papillary thyroid tumors, but as a privilege of thyroid carcinomas
in general. If total thyroidectomy is applied in all benign and malignant
thyroid diseases, the presence of multiple foci does not affect the progno-
sis and the survival of the patients.
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Obiettivo. Studio della frequenza della multifocalità nei carcino-
mi tiroidei ben differenziati non midollari e della sua correlazione con
diversi fattori epidemiologici, oltre che con la sopravivenza dei pazien-
ti.
Pazienti e metodi. Lo studio è stato condotto in 80 pazienti sotto-
posti a tiroidectomia totale dal gennaio 1985 al dicembre 2004 nel Pri-
mo Dipartimento di Chirurgia della Università della Tracia Democri-
tus, Grecia, per carcinoma ben differenzato (papillare e follicolare). Sono
stati analizzati età, sesso, tipo istologico, multifocalità dei tumori, so-
pravvivenza.
Risultati. La multifocalità è stata identificata in 17/80 pazienti
(21,25%). Tumore multifocalizzato è stato trovato in 4/20 (20%) e in
13/60 donne (21,67%), in percentuali quindi sovrapponibili. Alta fre-
quenza di multifocalità si è trovata nei seguenti gruppi di età 20-29,
30-39 e 70-79, bassa frequenza è stata trovata nei gruppi 0-9, 10-19
e 60-69 anni. La frequenza nei follicolari è stata del 20%, analoga a
quella dei papillari (22,2%). Invece, frequenza molto alta è stata tro-
vata nei tumori misti papillari-follicolari (75%). La sopravvivenza non
è influenzata dalla multifocalita del tumore. 
Conclusioni. La multifocalita non deve essere considerata un “pri-
vilegio” dei tumori tiroidei papillari, ma caratteristica comune dei car-
cinomi tiroidei. In caso di  tiroidectomia totale la presenza di multifo-
calita non influenza ovviamente la prognosi e la sopravvivenza del pa-
ziente.
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cy of multifocal papillary tumors vary in literature, rang-
ing from 18%, up to 87% (1-5). On the contrary, var-
ious studies report a multifocal trend of appearance in
follicular carcinomas as well (6-8), a form of presenta-
tion that in at least one study (9) affects the prognosis. 
We report a series of thyroid tumors with multifo-
cal origin, in which follicular tumors are found to be mul-
tifocal in at least the same frequency as the papillary tu-
mors.
Patients and methods
A retrospective study was conducted on 992 patients who un-
derwent total thyroidectomy from January 1985 to December 2004
in the First Department of Surgery of an academic tertiary referral
medical center (University General Hospital of Alexandroupolis, Dem-
ocritus University of Thrace, Greece) for several thyroid diseases. Well-
differentiated non-medullary thyroid cancer (papillary and follicu-
lar) was documented by histologic examination in 80 patients (8,1%).
Patients’ medical records and demographics, including age, gen-
der, histological type (papillary, follicular), multiple foci of tumors,
overall and specific survival were analyzed using Statistical Package
for the Social Sciences (SPSS), version 11.0 (SPSS, Inc., Chicago,
IL, USA). Multifocality was defined as the presence of  two or more
loci, at distinctive positions of the thyroid gland, at the final pathol-
ogy report.
Results 
Multifocality was documented in 17/80 patients
(21,25%). Multifocal tumors in the same thyroid lobe
as the primary site were found in 10/17 patients
(58,8%), while malignant foci in the contralateral lobe
were found in 7/17 patients (41,2%). The rate of patients
with disease influencing both thyroid lobes was 7/80 pa-
tients (8,8%).
Regarding gender, male patients were 20/80 (25%)
and female patients 60/80 (75%). Multifocal tumors were
found in 4/20 male patients (20%), while the female
group was presented with 13/60 ones with multiple loci
(21,67%), percentages which are almost identical, with-
out any statistical difference.
Age was another factor studied regarding the multi-
focality of thyroid cancer. The mean age of the study was
45,55 ± 15,05 years. Increased rates of multifocal tumors
were found in the age groups of 20-29, 30-39 and 70-
79 years old, with 36,4%, 30,8% and 33,3% respectively,
while low rates were documented in the age groups of
0-9, 10-19 and 60-69 years old (0%, 0% and 8,3%) (Fig.
1). Overall, a trend is observed, with multifocality ap-
pearing mainly in patients in the third and forth decade
of their life, while the increased rate in group 70-79 was
insignificant, due to the small number of patients
(1/3).
Histology was studies as another factor influencing
multifocality. Papillary tumors (papillary and mixed pap-
illary-follicular neoplasms, 45/80 patients) had a mul-
tifocality rate of 22,2% (10/45 patients), while follicu-
lar tumors (including Hürthle carcinomas, 35/80 patients)
had a 20% rate (7/35 patients), a rate similar to papil-
lary tumors. More thorough analysis showed impressive
multifocal rate of mixed papillary-follicular neoplasms
(75%), low frequency of papillary carcinomas (10,8%)
and multifocality rate of Hürthle carcinomas to be 0%,
while the rate of follicular carcinomas was found statis-
tically similar with that of the general population
(24,1%) (Fig. 2).
Overall survival in the study was 93,8% (75/80 pa-
tients), with a mean follow-up time of 95,25 ± 74,42
months. In the multifocality patients’ group, the survival
was found to be 94,1%, while in the patients with soli-
tary tumors’ group the survival was 93,7%, results that
are statistically identical, thus documenting that survival
is not influenced by the multifocality of the tumor, un-
der the prequisition that total thyroidectomy is applied.
Discussion 
Multifocality of thyroid carcinomas is a characteris-
tic documented in many patients undergoing surgery for
various benign and malignant thyroid diseases. This char-
acteristic is mainly identified in patients with papillary
thyroid cancer, a histologic type that mostly gives
metastases through the lymphatic system, which inside
the gland forms a network of intralobular lymphatic ves-
sels that connect the two lobes. In papillary carcinomas,
the rate of multiple foci varies in the literature, ranging
from 18% up to 87% (1-5). In our study, the rate of pap-
illary multifocal tumors was found to be 22,2%, a val-
ue similar to the lower rates reported in the literature and
similar to the overall rate of multifocality in our study
(21,25%). This low rate is probably due to the application
of total thyroidectomy for all benign diseases in our De-
partment, a surgical practice which diagnose papillary
microcarcinomas in an early stage, before producing in-
trathyroidal metastases. 
An extremely high rate of multifocality was found in
patients with follicular variant of papillary carcinomas
(75%). This is, to our knowledge, a result that is first doc-
umented in the literature, although the rate of multiple
foci in these patients is reported high  in some studies
(8). The authors believe that more studies should be de-
signed in this direction to verify this result or not, in or-
der to examine the possibility of a second look in the treat-
ment of patients with small incidental thyroid mixed-
type tumors. Authors believe that all thyroid malignancies,
even <1 cm, should be treated as potentially lethal, and
total thyroidectomy should be applied all cases.
Follicular tumors were found to have almost similar
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Fig. 1 - Age and multifocality.
Fig. 2 - Histologic type and multifocality.
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frequency of multifocality with papillary tumors (20%
vs 22,2%). This is another result of our study that is ex-
tremely interesting, since until nowadays, it is believed
that multifocality is a characteristic found in papillary
tumors. Some authors report high rate of multiple loci
in follicular neoplasms (6-8), but the rate of multifocality
in follicular cancer is not yet clarified. 
Hürthle-cell carcinomas were found to have a very
low (0%) rate of multifocality. This is a finding that, al-
though is recorder in a small population (6 patients),
comes in consent with previous studies (7, 8) which doc-
umented the very low frequency of multiple foci in this
type of cancer.
Gender was not found to be a significant factor for
the presence of multifocal tumors. On the contrary, age
was found to play a significant role in the appearance of
multifocality. From the results of our study, patients be-
tween 20-39 years old seem to have an increased risk for
developing multiple thyroid tumors. This result is very
important and should be put under further investigation,
in order to confirm it or not and to possibly re-exam-
ine the surgical treatment applied on these patients for
various benign and malignant diseases, and especially
multinodular goitre.
Finally, survival does not seem to be influenced by
the presence of multifocality in thyroid tumors. The sur-
vival rates in patients with or without multiple loci were
found to be identical, in contrast with previous studies
that report multifocality as a factor that worsens prog-
nosis (9). This is a finding that, although important,
should not misguide the surgeon in performing opera-
tions other than total thyroidectomy, because these re-
sults come from a Department that performs total thy-
roidectomy in all cases, thus eliminating the possibility
of presence of thyroid carcinomas in the contralateral lobe,
carcinomas that are misdiagnosed when performing less-
extensive procedures.
Conclusions 
Multifocality should not be considered as a “privilege”
of papillary thyroid tumors, but as a privilege of thyroid
carcinomas in general. It could be present in all histologic
types of non-medullary thyroid cancers, with a very high
frequency in follicular variants of papillary carcinomas,
especially in younger patients (20-39 years old). If total
thyroidectomy is applied in all benign and malignant thy-
roid diseases, the presence of multiple foci does not af-
fect the prognosis and the survival of the patients.
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